BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11294519)

  • 1. Adsorptive voltametry to determine platinum levels in plasma from testicular cancer patients treated with cisplatin.
    Gelevert T; Messerschmidt J; Meinardi MT; Alt F; Gietema JA; Franke JP; Sleijfer DT; Uges DR
    Ther Drug Monit; 2001 Apr; 23(2):169-73. PubMed ID: 11294519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors.
    Boer H; Proost JH; Nuver J; Bunskoek S; Gietema JQ; Geubels BM; Altena R; Zwart N; Oosting SF; Vonk JM; Lefrandt JD; Uges DR; Meijer C; de Vries EG; Gietema JA
    Ann Oncol; 2015 Nov; 26(11):2305-10. PubMed ID: 26347114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
    Hohnloser JH; Schierl R; Hasford B; Emmerich B
    Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patients.
    Boffetta P; Fichtinger-Schepman AM; Weiderpass E; van Dijk-Knijnenburg HC; Stoter G; van Oosterom AT; Keizer HJ; Fosså SD; Kaldor J; Roy P
    Anticancer Drugs; 1998 Feb; 9(2):125-9. PubMed ID: 9510497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer.
    Gietema JA; Meinardi MT; Messerschmidt J; Gelevert T; Alt F; Uges DR; Sleijfer DT
    Lancet; 2000 Mar; 355(9209):1075-6. PubMed ID: 10744098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study.
    Hjelle LV; Gundersen PO; Oldenburg J; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Bremnes RM; Haugnes HS
    Anticancer Res; 2015 Mar; 35(3):1619-25. PubMed ID: 25750319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy.
    Trendowski MR; El-Charif O; Ratain MJ; Monahan P; Mu Z; Wheeler HE; Dinh PC; Feldman DR; Ardeshir-Rouhani-Fard S; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Mushiroda T; Kubo M; Hannigan R; Strathmann F; Einhorn LH; Fossa SD; Travis LB; Dolan ME
    Clin Cancer Res; 2019 Oct; 25(19):5913-5924. PubMed ID: 31296530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay.
    Motzer RJ; Reed E; Perera F; Tang D; Shamkhani H; Poirier MC; Tsai WY; Parker RJ; Bosl GJ
    Cancer; 1994 Jun; 73(11):2843-52. PubMed ID: 7514956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term side effects of chemotherapy for testicular cancer].
    Kawai K
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1300-5. PubMed ID: 12146015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.
    Salas S; Mercier C; Ciccolini J; Pourroy B; Fanciullino R; Tranchand B; Monjanel-Mouterde S; Baciuchka-Palmaro M; Dupuis C; Yang C; Balti M; Lacarelle B; Duffaud F; Durand A; Favre R
    Ther Drug Monit; 2006 Aug; 28(4):532-9. PubMed ID: 16885721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer.
    Sprauten M; Darrah TH; Peterson DR; Campbell ME; Hannigan RE; Cvancarova M; Beard C; Haugnes HS; Fosså SD; Oldenburg J; Travis LB
    J Clin Oncol; 2012 Jan; 30(3):300-7. PubMed ID: 22184390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancer.
    Gerl A; Schierl R
    Acta Oncol; 2000; 39(4):519-22. PubMed ID: 11041115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid determination of platinum by flameless atomic absorption spectrophotometry following the administration of cisplatin to cancer patients.
    el-Yazigi A; Al-Saleh I
    Ther Drug Monit; 1986; 8(3):318-20. PubMed ID: 3750375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
    Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
    J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term complications of platinum-based chemotherapy in testicular cancer survivors.
    Oh JH; Baum DD; Pham S; Cox M; Nguyen ST; Ensor J; Chen I
    Med Oncol; 2007; 24(2):175-81. PubMed ID: 17848741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platinum concentrations in human tissue after administration of cisplatin].
    Tochigi T; Ono K; Yoshikawa K; Hoshi S; Orikasa S; Imai Y
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):269-75. PubMed ID: 3341789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term platinum excretion in patients treated with cisplatin.
    Schierl R; Rohrer B; Hohnloser J
    Cancer Chemother Pharmacol; 1995; 36(1):75-8. PubMed ID: 7720180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic determination of cisplatin as platinum(II) in a pharmaceutical preparation and blood samples of cancer patients.
    Khuhawar MY; Lanjwani SN; Memon SA
    J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):175-9. PubMed ID: 9200532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum metallothionein in patients with testicular cancer.
    Tariba B; Živković T; Krasnići N; Marijić VF; Erk M; Gamulin M; Grgić M; Pizent A
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):813-20. PubMed ID: 25700685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.